Search

everythinglearnresearchcommunity

for

Search:↓

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Patients often experience long-lasting changes to their hair after stem cell transplants.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

The meeting covered new findings in children's skin conditions and treatments, including the benefits of super absorbent polymer diapers.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.